Log In
BCIQ
Print this Print this
 

NADPH oxidase inhibitor

  Manage Alerts
Collapse Summary General Information
Company Alimera Sciences Inc.
DescriptionNADPH oxidase (NOX) inhibitor
Molecular Target NADPH oxidase
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat dry age-related macular degeneration (AMD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today